EZZ 14.1% $3.18 ezz life science holdings limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-23

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,454 Posts.
    lightbulb Created with Sketch. 477
    Q4 looks to me much more indicative on the underlying performance than Q3.

    The company had a cash flow from operation of 2 m$ during Q3, thanks to a large growth of their cash receipts (+ 111 % yoy).
    But, this cash flow was boosted by a major one off : "a substantial part of the cash inflow comes from delayed payments" (cf company Q3 quarterly disclosure).

    During Q4, the cash flow seems to be much more explained by the growth of the business : cash receipt growth was + 70 % yoy, with no mention by the company of a major one off effect in their cash receipt.
    It is also the reason why it is difficult to compare Q4 cash receipts with Q3 cash receipts (apart from the possible seasonality).
    The best indicator would be to compare Q4 revenues with Q3 revenues. Unfortunately, the company did not disclose these elements.
 
watchlist Created with Sketch. Add EZZ (ASX) to my watchlist
(20min delay)
Last
$3.18
Change
-0.520(14.1%)
Mkt cap ! $146.7M
Open High Low Value Volume
$3.70 $3.70 $3.14 $862.4K 259.3K

Buyers (Bids)

No. Vol. Price($)
1 683 $3.13
 

Sellers (Offers)

Price($) Vol. No.
$3.18 571 1
View Market Depth
Last trade - 16.10pm 04/11/2024 (20 minute delay) ?
EZZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.